Mar 04, 2021 / Presentations Mandated report: Relationship between clinician services and other Medicare services Research Areas: Drugs, Devices, and Tests, Physicians And Other Health Professionals
Mar 03, 2021 / Presentations Medicare vaccine coverage and payment Research Areas: Beneficiaries and Coverage, Drugs, Devices, and Tests
Jan 25, 2021 / Comment Letters MedPAC comment on CMS’s interim final rule on the Most Favored Nation Model Research Areas: Drugs, Devices, and Tests, Hospitals, Medicare Spending and Financing, Private Plans, Quality
Jan 20, 2021 / Transcripts January 2021 meeting transcript Research Areas: Ambulatory Care Settings, Beneficiaries and Coverage, Drugs, Devices, and Tests, Hospitals, Physicians And Other Health Professionals, Post-Acute Care, Private Plans, Quality
Jan 15, 2021 / Presentations Medicare’s vaccine coverage and payment policies Research Areas: Beneficiaries and Coverage, Delivery System Reforms, Drugs, Devices, and Tests
Jan 13, 2021 / Presentations Medicare vaccine coverage and payment policies Research Areas: Beneficiaries and Coverage, Drugs, Devices, and Tests
Nov 13, 2020 / Transcripts November 2020 meeting transcript Research Areas: Ambulatory Care Settings, Beneficiaries and Coverage, Delivery System Reforms, Drugs, Devices, and Tests, Hospitals, Physicians And Other Health Professionals, Private Plans, Quality, Regional Issues
Nov 10, 2020 / Presentations Separately payable drugs in the hospital outpatient prospective payment system Research Areas: Ambulatory Care Settings, Drugs, Devices, and Tests, Hospitals
Oct 02, 2020 / Comment Letters MedPAC comment on CMS’s proposed rule on the payment systems for hospital outpatient departments and ambulatory surgical centers for 2021 Research Areas: Ambulatory Care Settings, Drugs, Devices, and Tests, Hospitals, Medicare Spending and Financing
Oct 02, 2020 / Comment Letters MedPAC comment on CMS’s proposed rule on CY 2021 revisions to payment policies under the physician fee schedule and other changes to Part B payment policies Research Areas: Drugs, Devices, and Tests, Medicare Spending and Financing, Physicians And Other Health Professionals, Quality